2m 2m 2m 2m 2m 2m 2m
Evolutionary Gen (FNAM)
OTC
$0.0002$0.00 (0.00%)
Price as of Oct 31, 2025- $1,331.00Market Cap
- -75.00%1-Year Change
- BiotechnologyIndustry
Evolutionary Gen (FNAM)
$0.0002$0.00 (0.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.0002
$0.0002
$0.0002
1-Year Range
$0.0002
$0.0002
$0.0002
Latest Close$0.0002
Change
$0.00 (0.00%)
Volume1,000
Market Cap$1,331.00
Shares Outstanding6.7M
P/E (TTM)-0.0007
Diluted EPS (TTM)-$0.30
Enterprise Value$3.2M
Information as of 10/31/2025
Company Profile
EVOLUTIONARY GENOMICS, INC.
https://www.evolgen.com$1,331.00
Market Cap
-$1.9M
Net Income
Sector: Healthcare
Industry: Biotechnology
4220 Morning Star Drive, Castle Rock, CO, United States, 80108
720 900 8666Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.
Key Executives
- Walter Messier
- Steve Warnecke
- Virginia Orndorff
Current Ownership Distribution
- Other4.3M (64.64%)
- Insiders2.4M (35.36%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)